Liya Ding

1.7k total citations · 2 hit papers
21 papers, 1.3k citations indexed

About

Liya Ding is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Liya Ding has authored 21 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Liya Ding's work include PARP inhibition in cancer therapy (5 papers), interferon and immune responses (3 papers) and Epigenetics and DNA Methylation (3 papers). Liya Ding is often cited by papers focused on PARP inhibition in cancer therapy (5 papers), interferon and immune responses (3 papers) and Epigenetics and DNA Methylation (3 papers). Liya Ding collaborates with scholars based in United States, China and Finland. Liya Ding's co-authors include Haojie Huang, Panagiotis A. Konstantinopoulos, Thomas M. Roberts, Ursula A. Matulonis, Qiwei Wang, Shaozhen Xie, Hye‐Jung Kim, Liguo Wang, Jean J. Zhao and R. Jeffrey Karnes and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The EMBO Journal.

In The Last Decade

Liya Ding

21 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer

2018 395 citations Liya Ding, Hye‐Jung Kim et al. Cell Reports profile →
STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer

2022 163 citations Qiwei Wang, Johann S. Bergholz et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Liya Ding United States	15	831	468	394	342	171	21	1.3k
Xiuyan Yu China	16	412 0.5×	277 0.6×	264 0.7×	208 0.6×	107 0.6×	35	916
Chang Yang China	13	498 0.6×	250 0.5×	145 0.4×	339 1.0×	115 0.7×	37	953
X Chen China	20	781 0.9×	435 0.9×	128 0.3×	168 0.5×	55 0.3×	58	1.3k
Н. В. Литвяков Russia	18	405 0.5×	417 0.9×	154 0.4×	270 0.8×	143 0.8×	110	955
Qian Wu China	20	508 0.6×	383 0.8×	213 0.5×	285 0.8×	179 1.0×	81	1.1k
Jiahong Tan China	13	393 0.5×	168 0.4×	192 0.5×	171 0.5×	98 0.6×	29	781
Jie Ma China	18	451 0.5×	209 0.4×	149 0.4×	238 0.7×	157 0.9×	53	1.0k
Romi Gupta United States	19	650 0.8×	215 0.5×	134 0.3×	185 0.5×	87 0.5×	50	945
Sai-Wen Tang United States	15	698 0.8×	598 1.3×	229 0.6×	145 0.4×	108 0.6×	27	1.1k

Countries citing papers authored by Liya Ding

Since Specialization

Citations

This map shows the geographic impact of Liya Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liya Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liya Ding more than expected).

Fields of papers citing papers by Liya Ding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liya Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liya Ding. The network helps show where Liya Ding may publish in the future.

Co-authorship network of co-authors of Liya Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Liya Ding. A scholar is included among the top collaborators of Liya Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liya Ding. Liya Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Guanghui, et al.. (2024). Vitamin C ameliorates D-galactose-induced senescence in HEI-OC1 cells by inhibiting the ROS/NF-κB pathway. Molecular Biology Reports. 51(1). 1157–1157. 2 indexed citations

Ding, Liya, Qiwei Wang, Antons Martincuks, et al.. (2023). STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer. Journal for ImmunoTherapy of Cancer. 11(1). e005627–e005627. 62 indexed citations

Ding, Liya, Qiwei Wang, Antons Martincuks, et al.. (2022). 910 STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer. Regular and Young Investigator Award Abstracts. A948–A948. 3 indexed citations

Wang, Qiwei, Johann S. Bergholz, Liya Ding, et al.. (2022). STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer. Nature Communications. 13(1). 163 indexed citations breakdown →

Ding, Liya, Qiwei Wang, Michael Kearns, et al.. (2020). Abstract IA17: PARP inhibition modulates the tumor immune microenvironment in Brca1-deficient ovarian tumor. Clinical Cancer Research. 26(13_Supplement). IA17–IA17. 1 indexed citations

Zhao, Yu, Liya Ding, Dejie Wang, et al.. (2019). EZH 2 cooperates with gain‐of‐function p53 mutants to promote cancer growth and metastasis. The EMBO Journal. 38(5). 60 indexed citations

Ding, Liya, et al.. (2019). [Effects of hnRNP E1 and both early genes E2 and E6 of HPV16 together with their interactions on cervical carcinogenesis].. PubMed. 40(4). 466–470. 2 indexed citations

Ding, Liya, Hye‐Jung Kim, Qiwei Wang, et al.. (2018). PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer. Cell Reports. 25(11). 2972–2980.e5. 395 indexed citations breakdown →

Gang, Xiaokun, Yao Wang, Yingdi Wang, et al.. (2015). Suppression of casein kinase 2 sensitizes tumor cells to antitumor TRAIL therapy by regulating the phosphorylation and localization of p65 in prostate cancer. Oncology Reports. 34(3). 1599–1604. 6 indexed citations

10.

Wu, Changping, Xin Jin, H. J. Yang, et al.. (2015). Inhibition of EZH2 by chemo- and radiotherapy agents and small molecule inhibitors induces cell death in castration-resistant prostate cancer. Oncotarget. 7(3). 3440–3452. 42 indexed citations

11.

Wang, Dejie, Liya Ding, Liguo Wang, et al.. (2015). LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer. Oncotarget. 6(38). 41045–41055. 152 indexed citations

12.

Ding, Liya, Daiwen Chen, Ping Liu, et al.. (2014). CBP Loss Cooperates with PTEN Haploinsufficiency to Drive Prostate Cancer: Implications for Epigenetic Therapy. Cancer Research. 74(7). 2050–2061. 35 indexed citations

13.

Zhong, Jian, Liya Ding, Laura R. Bohrer, et al.. (2014). p300 Acetyltransferase Regulates Androgen Receptor Degradation and PTEN-Deficient Prostate Tumorigenesis. Cancer Research. 74(6). 1870–1880. 80 indexed citations

14.

Jiang, Wen‐An, Huaxiong Huang, Liya Ding, et al.. (2014). Regulation of cell cycle of hepatocellular carcinoma by NF90 through modulation of cyclin E1 mRNA stability. Oncogene. 34(34). 4460–4470. 59 indexed citations

15.

Ding, Liya, Yunqian Pan, Jian Zhong, et al.. (2014). CBP loss cooperates with PTEN haploinsufficiency to drive prostate cancer: implications for epigenetic therapy. 28 indexed citations

16.

Wang, Lan, Shuai Chen, Liya Ding, et al.. (2013). BRCA1 is a negative modulator of the PRC2 complex. The EMBO Journal. 32(11). 1584–1597. 92 indexed citations

17.

Hu, Xiaohui, Liya Ding, Weixue Huang, et al.. (2013). (−)-Epigallocatechin-3-gallate, a potential inhibitor to human dicarbonyl/l-xylulose reductase. The Journal of Biochemistry. 154(2). 167–175. 3 indexed citations

18.

Huang, Weixue, Liya Ding, Qiang Huang, et al.. (2010). Carbonyl reductase 1 as a novel target of (−)‐epigallocatechin gallate against hepatocellular carcinoma†. Hepatology. 52(2). 703–714. 58 indexed citations

19.

Liu, Shan, Lijie Ma, Weixue Huang, et al.. (2006). Decreased expression of the human carbonyl reductase 2 gene HCR2 in hepatocellular carcinoma. Cellular & Molecular Biology Letters. 11(2). 230–41. 17 indexed citations

20.

Ding, Liya, et al.. (1994). Purification and properties of the Escherichia coli K-12 NAD-dependent nucleotide diphosphosugar epimerase, ADP-L-glycero-D-mannoheptose 6-epimerase.. Journal of Biological Chemistry. 269(39). 24384–24390. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact